Successful management of thyroid cancer remains a challenge. Although retrospective
studies have improved our understanding of the natural history of the disease, numerous …

A large amount of scientific information has accumulated that facilitates risk stratification and
individualized treatment plans for patients with thyroid cancer. The issue contains essential …

The demography of differentiated thyroid cancers (DTCs) has changed considerably since
the 1990s, when the vast majority of these tumors were clinically evident at the time of …

Risk assessment is the cornerstone of contemporary management of thyroid cancer.
Following thyroid surgery, an initial risk assessment of recurrence and disease-specific …

Background The prognosis of well‐differentiated thyroid cancer has been stratified into low‐
and high‐risk groups. These risk groups can be used to predict prognosis and to guide …

Thyroid cancer is rare; however, the incidence continues to rise worldwide. Most patients will
be cured and can anticipate a normal life expectancy. It is therefore vital that this low …

Objective To reexamine the age, metastases, extent, and size (AMES) risk criteria for well-
differentiated thyroid cancer with the effect of therapy on outcome. Design Review of patient …

Guidelines for the management of differentiated thyroid cancer should continue to reflect
minor regional variations in thyroid cancer treatment based on factors unique to that …

Conclusion Thyroid cancer comprises a group of tumors with remarkably different features.
Owing to the rising incidence of thyroid cancer and recent advances in the management of …

Thyroid cancer is the most common of all endocrine cancers. Well-differentiated thyroid
cancer comprises the majority of thyroid cancers, about 90%, and includes both papillary …